DNMT1 and neoplasm: Recent papers have pointed out that DNMT1 catalyzes the promoter methylation of miR-148a in pancreatic cancer (Hong et al., 2018) and acute myeloid leukemia (Wang et al., 2019); moreover, the aberrant expression of microRNAs is associated with tumor progression.